云南高校图书馆联盟文献共享服务平台- MYELOMA

MYELOMA: 作品数：201被引量：248H指数：8; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：高文杰李恒辉王畅刘欣霍月红更多>>; 相关机构：华中科技大学大同市第五人民医院吉林大学第一医院吉林大学中日联谊医院更多>>; 相关期刊：更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划南京市卫生局科研基金齐齐哈尔市科学技术计划项目更多>>

NUF2 overexpression predicts poor outcomes in multiple myeloma: 《Genes & Diseases》2025年第1期141-143,共3页Shanshan Zhang Li Zhang Linjing Cai Huan Chen Yuqi Wang Youhai Yuan Hanzhen Zhang Xiaolei Wei; supported by Natural Science Foundation:of Guangdong,China(No.2024A04J5216);the Technology Project of Guangzhou City(Guangdong,China)(No.202102020937);the Outstanding Youth Development Scheme of Nanfang Hospital,Southern Medical University(Guangdong,China)(No.2019J011).; Multiple myeloma(MM)is the second most common hematologic malignancy and is characterized by the expansion of clonally plasma cells and related organ or tissue damage.1 The clinical behavior,response,and survival of M...; 关键词：MYELOMA CLINICAL DAMAGE

Dynamic frailty-tailored therapy(DynaFiT):A proof-of-concept study in elderly patients with newly diagnosed multiple myeloma: 《Blood Science》2024年第4期70-72,共3页Yun Dai Fengyan Jin; funded by the National Natural Science Foundation of China(No.81471165,81670190,81670189,81870160,81971108,82270207,and 82370202);the Science and Technology Development Program of the Jilin Province(No.20190201042JC,20190201163JC,YDZJ202301ZYTS021,and 20210509010RQ);Interdisciplinary Integration and Innovation Project of Jilin University.; Emerging evidence indicates that the fitness/frailty status of elderly patients with multiple myeloma(MM)is highly dynamic,influenced by factors such as aging,disease progression,and treatment.This underscores the imp...; 关键词：PATIENTS TREATMENT MYELOMA

A new autophagy-related nomogram and mechanism in multiple myeloma: 《Genes & Diseases》2024年第5期29-32,共4页Hanying Huang Yang Li Ziang Zhu Yang Liu Weida Wang Shuzhao Chen Xiaoping Wu Yun Wang Yanzhou Chen Huanxin Lin Yang Liang Lingling Shu; the Sun Yat-sen University Hundred Talents Program(China)(No.PT19200101);Natural Science Foundation of Guangdong Province,China(No.2022A1515010290);Guangdong Province Science and Technology Planning Project of China(No.2020A1414010033);Guangzhou Science and Technology Planning Project of China(No.202102020430);YL was supported,in part,by Sun Yat-sen University Start-up Funding(China)(No.201603);H-XL was supported by the National Natural Science Foundation of China(No.81773103);the Natural Science Foundation of Guangdong Province,China(No.2017A030313617).; Multiple myeloma(MM)is the second most common hematological tumor.It is characterized by high drug resistance,easy recurrence,and poor prognosis,and remains incurable.Various models or scoring modalities can be used t...; 关键词：METABOLISM PROGNOSIS MYELOMA

Coexistence of myeloproliferative neoplasms with multiple myeloma: 《Cancer Pathogenesis and Therapy》2024年第3期212-214,共3页Qiuqing Xiang Bin Chu Minqiu Lu Lei Shi Yutong Wang Lijuan Fang Yuan Chen Kai Sun Li Bao; supported by the Beijing Jishuitan Research Funding(No.ZR-202226).; Managing Editor:Peng Lyu Edited by:Lili Wang and Peng Lyu Myeloproliferative neoplasms(MPNs),including polycythemia vera(PV),essential thrombocythemia(ET),and primary myelofibrosis,originate from pluripotent hematopoi...; 关键词：NEOPLASMS PROLIFERATIVE MYELOMA

Application of the Second Revision of the International Staging System(R2-ISS)in the prognostic assessment of newly diagnosed multiple myeloma: 《China Medical Abstracts(Internal Medicine)》2024年第3期184-185,共2页YAN Jie; Objective To investigate the prognostic value of the Second Revision of the International Staging System (R2-ISS) in patients with newly diagnosed multiple myeloma(NDMM).Methods The retrospective study was performed i...; 关键词：DRUGS MYELOMA Clinical

Extensive Bi-Atrial Remodeling on Hypertensive Patient with Permanent Atrial Fibrillation Delayed Diagnosis of Fatal Cardiac Lambda Amyloidosis: 《World Journal of Cardiovascular Diseases》2024年第6期409-420,共12页Houzéiph Abdou Lassissi Ngardjibem Djita Ibrahima Sory Sylla Thome Masset Abdelrhani Moumen Sedjolo Emmanuelle Bibiane Kpomalegni; Background: Amyloidosis is a disease characterized by the deposition of fibrillar proteins in tissues. The nature of the protein defines the type of amyloidosis. Cardiac involvement is most often secondary to deposits...; 关键词：MYELOMA Cardiac Lambda Light Chain Amyloidosis Monoclonal Gammopathy Heart Failure

Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effects: 《Cancer Drug Resistance》2024年第1期604-619,共16页Seiichi Okabe Yuko Tanaka Mitsuru Moriyama Akihiko Gotoh; approved by the Ethics Committee of Tokyo Medical University(No.T2023-0105).; Aim:This study aimed to investigate drug candidates and their efficacy in treating refractory multiple myeloma(MM)despite significant therapeutic advances and the introduction of novel agents.Our study focused on how ...; 关键词：Multiple myeloma GLUTAMINOLYSIS GLS1 HDAC inhibitor

A single-center retrospective analysis of autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma in the elderly: 《China Medical Abstracts(Internal Medicine)》2024年第1期55-55,共1页王婧; Objective To evaluate the efficacy and safety of autologous hematopoietic stem cell transplantation (autoHSCT) for the treatment of multiple myeloma (MM) in elderly patients aged over 65 years.Methods In this retrospe...; 关键词：HEMATOPOIETIC MYELOMA TREATMENT

Bendamustine combined with pomalidomide and dexamethasone in relapsed multiple myeloma with extramedullary disease:a multicenter study: 《China Medical Abstracts(Internal Medicine)》2023年第4期235-236,共2页吴弘英; Objective To evaluate the efficacy and safety of bendamustine combined with pomalidomide and dexamethasone(BPD regimen)in the treatment of relapsed multiple myeloma(MM)with extramedullary disease.Methods This open,sin...; 关键词：MEDULLARY RELAPSE MYELOMA

From Myeloma to Plasma Cell Leukemia, Persistent Inequalities: 《Open Journal of Blood Diseases》2023年第4期133-140,共8页Mamadou Wague Gueye Nata Dieng Maguette Ndoye Mor Ngom Sokhna Moumi Mbacké Daffé Papa Silman Diawara Macoura Gadji Ndèye Marième Diagne Bécaye Fall; Multiple myeloma (MM) is both a complex and heterogeneous disease. Cytogenetic and molecular abnormalities lead to resistance to treatment and transformation to plasma cell leukemia, which is defined by the presence i...; 关键词：Multiple Myeloma Plasma Cells Leukemia Personalized Medicine Risk Stratification

MYELOMA